V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002462 | 230011705 | 1.59 | 60 | null | 2018-03-09 | 2021-07-06 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100217599 |
| 230002075 | 230011707 | 1.6 | 82.2 | null | 2019-11-18 | 2020-09-01 | null | null | null | BEVACIZUMAB | 101208932 |
| 230001673 | 230011709 | null | null | null | null | 2019-09-01 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101631811 |
| 230001090 | 230011737 | null | null | null | null | 2021-04-10 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101585337 |
| 230001124 | 230011739 | 1.66 | 63.4 | Palliative (P) | null | 2020-07-06 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101545559 |
| 230001135 | 230011740 | null | null | null | null | 2021-12-15 | null | null | null | CARBOPLATIN + PACLITAXEL | 100186203 |
| 230001145 | 230011741 | null | null | null | null | 2022-01-06 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101777462 |
| 230001173 | 230011742 | 1.48 | null | null | 2022-03-24 | 2022-04-11 | null | null | null | CARBOPLATIN + PACLITAXEL | 100000472 |
| 230001361 | 230011748 | 1.63 | 68.95 | Adjuvant (A) | 2019-02-24 | 2019-03-20 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100539577 |
| 230001424 | 230011751 | 1.65 | 55.2 | 03 | 2022-01-15 | 2022-01-26 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101077543 |
| 230001430 | 230011752 | 1.6 | 55.1 | null | null | 2022-04-18 | PEMBROLIZUMAB | N | null | CARBOPLATIN | 101396392 |
| 230001434 | 230011753 | null | null | null | null | 2022-01-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100300880 |
| 230001590 | 230011757 | null | null | Palliative (P) | 2020-01-18 | 2022-04-15 | null | 02 | N | TRIAL UNSPECIFIED | 100381159 |
| 230001653 | 230011758 | null | null | null | null | 2019-06-23 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101812817 |
| 230001662 | 230011759 | 1.59 | 61.5 | Palliative (P) | null | 2018-08-03 | Cisplatin 7 day | 02 | N | TRIAL UNSPECIFIED | 100739333 |
| 230001787 | 230011762 | null | null | Palliative (P) | 2020-08-18 | 2021-08-13 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101286448 |
| 230001809 | 230011763 | 1.76 | 59 | null | 2021-01-07 | 2021-01-27 | Bevacizumab 7.5mg/kg | 01 | null | ICON8B TRIAL | 100132664 |
| 230001812 | 230011764 | 1.58 | 77.5 | null | 2022-02-10 | 2022-02-11 | null | 02 | null | CISPLATIN + DOXORUBICIN | 101686049 |
| 230001835 | 230011765 | 1.64 | 74.5 | null | null | 2021-12-07 | Rucaparib | 02 | null | RUCAPARIB | 101058651 |
| 230001939 | 230011768 | null | null | Palliative (P) | null | 2019-02-19 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100510619 |
| 230001955 | 230011771 | 1.58 | 60.9 | null | 2021-05-26 | 2021-05-30 | Liposomal Doxorubicin 40mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 100203421 |
| 230001982 | 230011772 | 1.7 | 81.6 | Palliative (P) | null | 2018-11-01 | null | null | N | NIRAPARIB | 101163629 |
| 230002078 | 230011773 | 1.68 | 60.9 | Neo-adjuvant (N) | null | 2021-06-01 | Olaparib | 02 | N | OLAPARIB | 101221344 |
| 230002164 | 230011777 | 1.66 | 73 | null | 2021-08-02 | 2021-11-10 | Niraparib | 02 | null | NIRAPARIB | 100317806 |
| 230002341 | 230011780 | 1.63 | 62 | null | 2021-07-21 | 2021-07-21 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101105721 |
| 230002349 | 230011781 | 1.63 | 52.4 | null | 2021-10-01 | 2021-10-05 | null | null | null | PACLITAXEL | 100379957 |
| 230002412 | 230011783 | 1.74 | 76.55 | Adjuvant (A) | 2021-03-08 | 2021-03-14 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101528187 |
| 230002462 | 230011786 | 1.63 | 77.6 | null | 2021-12-27 | 2021-12-28 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100217599 |
| 230001135 | 230011810 | null | null | null | null | 2022-02-02 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100186203 |
| 230001235 | 230011813 | null | null | null | null | 2022-02-11 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101312298 |
| 230001787 | 230011825 | 1.65 | 88 | Palliative (P) | 2021-09-03 | 2021-10-11 | Bevacizumab | 02 | N | BEVACIZUMAB | 101286448 |
| 230001809 | 230011826 | 1.55 | 64 | null | 2021-01-23 | 2021-02-06 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100132664 |
| 230001880 | 230011829 | 1.57 | 70.4 | null | null | 2022-01-28 | PACLITAXEL | 02 | null | PACLITAXEL | 101351228 |
| 230001955 | 230011831 | 1.58 | 66.2 | null | 2021-03-14 | 2021-06-04 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100203421 |
| 230002117 | 230011834 | 1.58 | 83 | Palliative (P) | null | 2022-05-16 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100477391 |
| 230002219 | 230011836 | 1.66 | 58 | Palliative (P) | null | 2022-03-21 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100788570 |
| 230002349 | 230011839 | null | null | null | 2021-10-31 | 2021-11-11 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100379957 |
| 230002456 | 230011842 | 1.67 | 86.5 | null | 2020-12-07 | 2021-04-16 | null | null | null | BEVACIZUMAB | 101871570 |
| 230002462 | 230011843 | 1.56 | 65 | null | 2022-01-01 | 2022-02-01 | null | 01 | null | NIVOLUMAB | 100217599 |
| 230002484 | 230011844 | 1.65 | 70.4 | Palliative (P) | null | 2019-01-23 | null | null | N | PEMBROLIZUMAB | 101190704 |
| 230002075 | 230011845 | 1.64 | 71.3 | null | 2020-08-15 | 2020-09-29 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101208932 |
| 230001344 | 230011862 | null | null | null | null | 2021-12-03 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 100946609 |
| 230001809 | 230011869 | 1.68 | 62.2 | null | null | 2021-02-27 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100132664 |
| 230001939 | 230011871 | null | null | Adjuvant (A) | 2018-11-03 | 2019-03-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100510619 |
| 230001955 | 230011872 | null | null | null | null | 2021-07-03 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100203421 |
| 230002078 | 230011873 | 1.62 | 63.2 | null | null | 2021-06-08 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101221344 |
| 230002219 | 230011875 | null | null | null | 2022-03-16 | 2022-03-21 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100788570 |
| 230002341 | 230011877 | 1.53 | 56 | null | 2021-09-12 | 2021-09-16 | Niraparib | 02 | null | NIRAPARIB | 101105721 |
| 230002349 | 230011878 | 1.59 | 76.55 | Adjuvant (A) | 2021-12-22 | 2021-12-26 | Carboplatin + Liposomal Doxorubicin | 02 | N | ETOPOSIDE | 100379957 |
| 230002484 | 230011882 | 1.52 | 70.9 | Palliative (P) | null | 2019-02-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101190704 |